A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
Clinical trial NCT06153251 · RECRUITING
Trial details
- NCT number
- NCT06153251
- Sponsor
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-23
- Primary completion
- 2030-05-02
- Enrollment
- 187
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.